Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 3/2013

01-06-2013

Is Integrative Medicine the Next New Frontier in Medicine?

Author: Christopher Chang

Published in: Clinical Reviews in Allergy & Immunology | Issue 3/2013

Login to get access

Abstract

Complementary and alternative medicine (CAM) methods are increasingly being used by patients in the Western world to treat autoimmune or allergic diseases. Patients use these methodologies of their own accord, frequently against the advice of their physicians. Integrative medicine hopes to merge the benefits of both conventional Western medicine and CAM. More and more research is being conducted to decipher the secrets behind the thousands of years of experience that CAM offers. Are these treatments effective, and are they safe? Or do they act simply by the “placebo effect.” This unique issue attempts to bring integrative medicine to greater awareness among Western physicians and practitioners.
Literature
1.
go back to reference Costenbader KH, Gay S, Alarcon-Riquelmy ME, Iaccarino L, Doria A (2012) Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? Autoimmun Rev 11:604–609PubMedCrossRef Costenbader KH, Gay S, Alarcon-Riquelmy ME, Iaccarino L, Doria A (2012) Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? Autoimmun Rev 11:604–609PubMedCrossRef
2.
go back to reference Murdaca G, Colombo BM, Puppo F (2011) Emerging biological drugs: a new therapeutic approach for systemic lupus erythematosus. An update upon efficacy and adverse events. Autoimmun Rev 11:56–60PubMedCrossRef Murdaca G, Colombo BM, Puppo F (2011) Emerging biological drugs: a new therapeutic approach for systemic lupus erythematosus. An update upon efficacy and adverse events. Autoimmun Rev 11:56–60PubMedCrossRef
3.
go back to reference Xiong FL, Chen HB, Chang XL, Yang YJ, Xu HB, Yang XL (2005) Research progress of triptolide-loaded nanoparticles delivery systems. Conf Proc IEEE Eng Med Biol Soc 5:4966–9PubMed Xiong FL, Chen HB, Chang XL, Yang YJ, Xu HB, Yang XL (2005) Research progress of triptolide-loaded nanoparticles delivery systems. Conf Proc IEEE Eng Med Biol Soc 5:4966–9PubMed
4.
go back to reference Brooks WH (2012) Mechanisms and pathophysiology of autoimmune disease. Clin Rev Allergy Immunol 42:1–4PubMedCrossRef Brooks WH (2012) Mechanisms and pathophysiology of autoimmune disease. Clin Rev Allergy Immunol 42:1–4PubMedCrossRef
6.
go back to reference NCCAM. The use of complementary and alternative medicine in the United States, 2008:1-4. NCCAM. The use of complementary and alternative medicine in the United States, 2008:1-4.
7.
go back to reference Philp JC, Maselli J, Pachter LM, Cabana MD (2012) Complementary and alternative medicine use and adherence with pediatric asthma treatment. Pediatrics 129:e1148–1154PubMedCrossRef Philp JC, Maselli J, Pachter LM, Cabana MD (2012) Complementary and alternative medicine use and adherence with pediatric asthma treatment. Pediatrics 129:e1148–1154PubMedCrossRef
8.
go back to reference Misery L (2011) Atopic dermatitis: new trends and perspectives. Clin Rev Allergy Immunol 41:296–7PubMedCrossRef Misery L (2011) Atopic dermatitis: new trends and perspectives. Clin Rev Allergy Immunol 41:296–7PubMedCrossRef
9.
go back to reference Ma X, Zheng C, Hu C, Rahman K, Qin L (2011) The genus Desmodium (Fabaceae)—traditional uses in Chinese medicine, phytochemistry and pharmacology. J Ethnopharmacol 138:314–32PubMedCrossRef Ma X, Zheng C, Hu C, Rahman K, Qin L (2011) The genus Desmodium (Fabaceae)—traditional uses in Chinese medicine, phytochemistry and pharmacology. J Ethnopharmacol 138:314–32PubMedCrossRef
10.
go back to reference WHO. Acupuncture: review and analysis of controlled clinical trials. World Health Organization, 2003:1-87. WHO. Acupuncture: review and analysis of controlled clinical trials. World Health Organization, 2003:1-87.
11.
go back to reference Chen X, Oppenheim JJ, Howard OM (2004) Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components. Cell Mol Immunol 1:336–42PubMed Chen X, Oppenheim JJ, Howard OM (2004) Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components. Cell Mol Immunol 1:336–42PubMed
12.
go back to reference Cayetano KS, Chan AL, Albertson TE, Yoneda KY (2011) Bronchial thermoplasty: a new treatment paradigm for severe persistent asthma. Clin Rev Allergy Immunol. doi:10.1007/s12016-011-8295-6 Cayetano KS, Chan AL, Albertson TE, Yoneda KY (2011) Bronchial thermoplasty: a new treatment paradigm for severe persistent asthma. Clin Rev Allergy Immunol. doi:10.​1007/​s12016-011-8295-6
14.
go back to reference Chao CC, Chen SJ, Adamopoulos IE, Davis N, Hong K, Vu A et al (2011) Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis. Autoimmunity 44:243–52PubMedCrossRef Chao CC, Chen SJ, Adamopoulos IE, Davis N, Hong K, Vu A et al (2011) Anti-IL-17A therapy protects against bone erosion in experimental models of rheumatoid arthritis. Autoimmunity 44:243–52PubMedCrossRef
15.
go back to reference Duroux-Richard I, Presumey J, Courties G, Gay S, Gordeladze J, Jorgensen C et al (2011) MicroRNAs as new player in rheumatoid arthritis. Joint Bone Spine 78:17–22PubMedCrossRef Duroux-Richard I, Presumey J, Courties G, Gay S, Gordeladze J, Jorgensen C et al (2011) MicroRNAs as new player in rheumatoid arthritis. Joint Bone Spine 78:17–22PubMedCrossRef
16.
go back to reference Nussinovitch U, Shoenfeld Y (2012) The role of gender and organ specific autoimmunity. Autoimmun Rev 11:A377–85PubMedCrossRef Nussinovitch U, Shoenfeld Y (2012) The role of gender and organ specific autoimmunity. Autoimmun Rev 11:A377–85PubMedCrossRef
17.
go back to reference Hong J, Buddenkotte J, Berger TG, Steinhoff M (2011) Management of itch in atopic dermatitis. Semin Cutan Med Surg 30:71–86PubMedCrossRef Hong J, Buddenkotte J, Berger TG, Steinhoff M (2011) Management of itch in atopic dermatitis. Semin Cutan Med Surg 30:71–86PubMedCrossRef
Metadata
Title
Is Integrative Medicine the Next New Frontier in Medicine?
Author
Christopher Chang
Publication date
01-06-2013
Publisher
Humana Press Inc
Published in
Clinical Reviews in Allergy & Immunology / Issue 3/2013
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-012-8313-3

Other articles of this Issue 3/2013

Clinical Reviews in Allergy & Immunology 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine